Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Citicoline Treatment of Methamphetamine Dependence

NCT00950352 is registered in ClinicalTrials.gov with Perry Renshaw as lead sponsor.

NCT NCT00950352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00950352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Citicoline Treatment of Methamphetamine Dependence
Lead sponsor
Perry Renshaw
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2010
Completion date
December 31, 2012
Enrollment
104 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

methamphetamine dependence